NCT03100032 - Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2021

Study Completion Date

June 30, 2021

Conditions

Spondylolisthesis

Interventions

BIOLOGICAL

NVD-001

At the Investigator's discretion, one or two interbody polyetheretherketone (PEEK) cage(s) filled and surrounded with NVD-001.

PROCEDURE

Standard of Care

At the Investigator's discretion, one or two interbody polyetheretherketone (PEEK) cage(s) filled and surrounded with autologous locally cancellous bone (laminectomy)

Trial Locations (12)

1070

Hôpital Erasme - Neurosurgery Department, Brussels

1090

Universitair ziekenhuis Brussel - Brussels Health Campus - Department of Orthopaedics and Traumatology, Brussels

1200

Saint-Luc University Hospital, Brussels

2100

Algemeen Ziekenhuis Monica O.L.V. - Campus Deurne, Deurne

3600

Ziekenhuis Oost-Limburg, Campus Sint-Jan, Genk

5530

Centre Hosp. Univ. UCL - Namur site Godinne - Service de neurochirurgie, Yvoir

625 00

Fakultní nemocnice Brno, Brno

150 06

Fakultní nemocnice v Motole, Prague

80-952

Uniwersyteckie Centrum Kliniczne, Gdansk

40-611

Centrum Medyczne Angelius Provita, Katowice

30-693

Szpital Św. Rafała, Krakow

61-545

Ortopedyczno-Rehabilitacyjny Szpital Kliniczny im. W. Degi Uniwersytetu Medycznego im. Karola Marcinkowskiego, Poznan